FIGURE 1.

Experimental design. C₂C₁₂ myotubes at 5 days of differentiation were used for RIP‐seq experiments using previously validated anti‐RBM3 antibody (Pilotte et al., 2009). N = 3 biological replicates per condition (IP or IgG control).